Ngu Jing Hieng, Gearry Richard Blair, Wright Andrew Jeffrey, Stedman Catherine Ann Malcolm
Department of Gastroenterology, Christchurch Hospital, Private bag 4710, Christchurch, Canterbury, New Zealand.
University of Otago, Christchurch, Canterbury, New Zealand.
Hepatol Int. 2012 Oct;6(4):796-800. doi: 10.1007/s12072-011-9329-0. Epub 2011 Dec 15.
Epidemiological data on primary biliary cirrhosis (PBC) in the Southern Hemisphere is scarce. Our aim was to perform a population-based epidemiological study of PBC in Canterbury, New Zealand.
Multiple case-finding methods were employed. All public and private, adult and pediatric outpatient clinics, hospital discharge summaries, and laboratory and pathology reports were searched to identify all cases in the region. Cases were included if at least two of the following criteria were fulfilled: (1) positive anti-mitochondrial antibodies, (2) elevated alkaline phosphatase for greater than 6 months, and (3) compatible liver histology.
A total of 71 cases of PBC were included. The incidence in 2008 was 0.8 (95% confidence interval (CI) 0.1-1.6) per 100,000. The point prevalence on December 31, 2008 was 9.9 (95% CI 7.1-12.7) per 100,000. Male to female ratio was 1:11. At presentation, 45% were asymptomatic. Age at diagnosis peaked at the seventh decade with mean age at diagnosis of 61 (95% CI 58-64).
This is the first population-based epidemiological study of PBC conducted in New Zealand and only the second in the Southern Hemisphere. The incidence and prevalence are lower than the Northern Hemisphere, even though the majority of our population has shared genetic background with some of these countries. Our study has provided further support to the hypothesis that there may be a protective effect or lack of a risk factor for PBC in New Zealand.
南半球原发性胆汁性肝硬化(PBC)的流行病学数据匮乏。我们的目的是在新西兰坎特伯雷地区开展一项基于人群的PBC流行病学研究。
采用多种病例发现方法。检索了所有公立和私立的成人及儿科门诊诊所、医院出院小结以及实验室和病理报告,以确定该地区的所有病例。若满足以下至少两条标准,则纳入病例:(1)抗线粒体抗体阳性;(2)碱性磷酸酶升高超过6个月;(3)肝脏组织学表现相符。
共纳入71例PBC病例。2008年的发病率为每10万人0.8(95%置信区间(CI)0.1 - 1.6)。2008年12月31日的点患病率为每10万人9.9(95%CI 7.1 - 12.7)。男女比例为1:11。就诊时,45%无症状。诊断时的年龄高峰在第七个十年,诊断时的平均年龄为61岁(95%CI 58 - 64)。
这是在新西兰开展的第一项基于人群的PBC流行病学研究,也是南半球的第二项此类研究。尽管我们大多数人口与其中一些国家有共同的遗传背景,但发病率和患病率低于北半球。我们的研究进一步支持了以下假设:在新西兰可能存在对PBC的保护作用或缺乏危险因素。